Biotech Stock Advaxis: Outperformer In The Making

We identified bullish energy in the biotech sector 3 months ago. Since then, we posted several biotech stock picks which have done extremely well.

One of the very promising biotech companies which we covered in May of this year is Advaxis (ADXS). It is a small cap with a $467M market cap with a potential solution to weaken cancer.

We observed a low trading volumes in Advaxis back in May, but, since then, volume has become surged, and the picture looks very healthy right now.

The most encouraging sign of Advaxis’ chart is its breakout, the successful retest registered this week, combined with increased trading volume.

What does all that mean? Very simple, it is a strong BUY signal. In other words, Advaxis is an upcoming outperformer in the biotech sector, a sector leader in the making, one that has the potential to at least double in the coming months.

Disclaimer: makes every effort to ensure that the information ...

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.